GlyCardial Diagnostics has completed patient recruitment in EDICA trial: a multicenter international clinical study for the early detection of Myocardial Ischaemia.
We are honoured to announce that our CEO Judit Cubedo has been selected as finalist for the EU Prize for Women Innovators 2020!
GlyCardial Diagnostics incorporates Prof. Juan Carlos Kaski as Chief Medical Officer to oversee the Clinical Development.
GlyCardial Diagnostics starts the enrolment of patients in EDICA trial: a multicenter international clinical study for the early detection of Myocardial Ischaemia.
GlyCardial Diagnostics receives 1.9M€ from the SME Instrument Phase II H2020 Programme to advance in the development of the novel test for the early detection of cardiac ischemia.